Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Aftimoon has potential health benefits for various diseases and could be integrated into modern healthcare.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Ritlecitinib is safe and may effectively treat alopecia areata.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Amitraz effectively treated sarcoptic mange in three alpacas.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Topical tofacitinib is effective and safe for treating alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.